References
- 1. Njue A, Coyne C, Margulis AV, Wang D, Marks MA, Russell K, et al. The role of congenital cytomegalovirus infection in adverse birth outcomes: A review of the potential mechanisms. Viruses. 2021;13:20.
- 2. Patro ARK. Subversion of immune response by human cytomegalovirus. Front Immunol. 2019;10:1155.
- 3. Zuhair M, Smit GSA, Wallis G, Jabbar F, Smith C, et al. Estimation of the worldwide seroprevalence of cytomegalovirus: A systematic review and meta-analysis. Rev Med Virol. 2019;29:e2034.
- 4. Saldan A, Forner G, Mengoli C, Gussetti N, Palu G, Abate D. Testing for cytomegalovirus in pregnancy. J Clin Microbiol. 2017;55:693-702.
- 5. Fisher S, Genbacev O, Maidji E, Pereira L. Human cytomegalovirus infection of placental cytotrophoblasts in vitro and in utero: Implications for transmission and pathogenesis. J Virol. 2000;74: 6808-20.
- 6. Maltepe E, Fisher SJ. Placenta: the forgotten organ. Ann Rev Cell Dev Biol. 2015;31:523-52.
- 7. Resnik R, Lockwood CJ, Moore T, Greene MF, Copel JA, Silver RM. Creasy and Resnik’s maternal-fetal medicine: principles and practice. 8th ed. Philadelphia: Elsevier; 2019.
- 8. Hustin J, Schaaps JP. Echographic [corrected] and anatomic studies of the maternotrophoblastic border during the first trimester of pregnancy. Am J Obstet Gynecol. 1987;157:162-8.
- 9. Jauniaux E, Watson AL, Hempstock J, Bao YP, Skepper JN, Burton GJ. Onset of maternal arterial blood flow and placental oxidative stress. A possible factor in human early pregnancy failure. Am J Pathol. 2000;157:2111-22.
- 10. Castellucci M, Scheper M, Scheffen I, Celona A, Kaufmann P. The development of the human placental villous tree. Anat Embryol (Berl). 1990;181:117-28.
- 11. Kaufmann P, Mayhew TM, Charnock-Jones DS. Aspects of human fetoplacental vasculogenesis and angiogenesis. II. Changes during normal pregnancy. Placenta. 2004;25:114-26.
- 12. Ahmed A, Perkins J. Angiogenesis and intrauterine growth restriction. Baillieres Best Pract Res Clin Obstet Gynaecol. 2000;14: 981-98.
- 13. Frater JL, Kay NE, Goolsby CL, Crawford SE, Dewald GW, Peterson LC. Dysregulated angiogenesis in B-chronic lymphocytic leukemia: Morphologic, immunohistochemical, and flow cytometric evidence. Diagn Pathol. 2008;3:16.
- 14. Cannon MJ. Congenital cytomegalovirus (CMV) epidemiology and awareness. J Clin Virol. 2009;46:6-10.
- 15. Tastad KJ, Schleiss MR, Lammert SM, Basta NE. Awareness of congenital cytomegalovirus and acceptance of maternal and newborn screening. PLoS ONE. 2019;14(8):e0221725.
- 16. Thackeray R, Magnusson BM. Women’s attitudes toward practicing cytomegalovirus prevention behaviors. Prev Med Rep. 2016;4:517-24.
- 17. Charan J, Biswas T. How to calculate sample size for different study designs in medical research? Indian J Psychol Med. 2013;35(2):121-6.
- 18. Jeon J, Victor M, Adler SP, Arwady A, Demmler G, Fowler K, et al. Knowledge and awareness of congenital cytomegalovirus among women. Infect Dis Obstet Gynecol. 2006;2006:80383.
- 19. Galan HL, Pandipati S, Filly RA. Ultrasound evaluation of fetal biometry and normal and abnormal fetal growth. In: Ultrasonography in obstetrics and gynecology. 5th edition. Edited by Callen PW. USA: Saunders Elsevier; 2008: 225-65.
- 20. Al-kaabi M, Noel KI, Al-rubai A. Evaluation of immunohisto-chemical expression of stem cell markers (NANOG and CD133) in normal, hyperplastic, and malignant endometrium. J Med Life. 2022;15(1):117-23.
- 21. Hameed AF, Ibraheem MM, Ahmed BS. C-MYC and BCL2 expression in normal tissue around proliferative breast conditions in relation to ER, PR in a sample of Iraqi women. UKJPB. 2018;6(3):1-6.
- 22. Pereira L, Maidji E. Cytomegalovirus infection in the human placenta: Maternal immunity and developmentally regulated receptors on trophoblasts converge. Curr Top Microbiol Immunol. 2008;325:383-95.
- 23. Weisblum Y, Panet A, Haimov-Kochman R, Wolf DG. Models of vertical cytomegalovirus (CMV) transmission and pathogenesis. Semin Immunopathol. 2014;36:615-25.
- 24. Barut F, Barut A, Gun BD, Kandemir NO, Harma MI, Harma M, et al. Intrauterine growth restriction and placental angiogenesis. Diagnostic Pathology. 2010;5:24.
- 25. Weckman AM, Ngai M, Wright J, McDonald CR, Kain KC. The Impact of infection in pregnancy on placental vascular development and adverse birth outcomes. Front Microbiol. 2019;10:1924.
- 26. Wang Y, Zhao S. Vascular biology of the placenta. San Rafael: Morgan & Claypool Life Sciences; 2010.
- 27. Demir R, Seval Y, Huppertz B. Vasculogenesis and angiogenesis in the early human placenta. Acta Histochem. 2007;109:257-65.
- 28. Kinzler WL, Vintzileos AM. Fetal growth restriction. Curr Opin Obstet Gynecol. 2008;2:125-31.
- 29. Mayhew TM, Charnock-Jones DS, Kaufmann P. Aspects of human fetoplacental vasculogenesis and angiogenesis. III. Changes in complicated pregnancies. Placenta. 2004;25:127-39.
- 30. Ferrara N. Vascular endothelial growth factor: Basic science and clinical progress. Endocrine Rev. 2004;25(4):581-611.
- 31. Searles CD. Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression. Am J Physiol Cell Physiol. 2006;291:C803-C16.
- 32. Lyall F, Young A, Boswell F, Kingdom JCP, Greer IA. Placental expression of vascular endothelial growth factor in placentae from pregnancies complicated by pre-eclampsia and intrauterine growth restriction does not support placental hypoxia at delivery. Placenta. 1997;18:269-76.
- 33. Noris M, Todeschini M, Cassis P, Pasta F, Cappellini A, Bonazzola S. L-arginine depletion in preeclampsia orients nitric oxide synthase toward oxidant species. Hypertension. 2004;43:614-22.
- 34. Jeon J, Victor M, Adler S, Arwady A, Demmler G, Fowler K, et al. Knowledge and awareness of congenital cytomegalovirus among women. Infect Dis Obstet Gynecol. 2006;2006:80383.
- 35. Doutre SM, Barrett TS, Greenlee J, White KR. Losing ground: Awareness of congenital cytomegalovirus in the United States. JHEDI. 2016;1(2):39-48
- 36. Aljumaili ZKM, Alsamarai AM, Najem WS. Cytomegalovirus seroprevalence in women with bad obstetric history in Kirkuk, Iraq. J Infect Public Health. 2014;7(4):277-88.